Ipca Laboratories Ltd share price logo

Ipca Laboratories Ltd Share Price

(IPCALAB)

Mid Cap

Healthcare Sector

Check the latest share price of Ipca Laboratories Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹1371.6▲0.72%

as on 04:01PM, 12 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Ipca Laboratories Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹1,335.3
    Day's Price Range
    ₹1,386.8

  • 52 Week's Low

    52 Week's High

    ₹1,052
    52-Week Price Range
    ₹1,755.9
1 Month Return-0.45 %
3 Month Return-4.09 %
1 Year Return+ 4.89 %
3 Year Return+ 41.62 %
5 Year Return+ 76.22 %
Previous Close₹1,361.80
Open₹1,386.80
Volume1.75L
Upper Circuit₹1,634.10
Lower Circuit₹1,089.50

Ipca Laboratories Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹34,549.44 Cr

Return on Equity (ROE)

9.81

PE Ratio (TTM)

47.35

Return on capital employed (ROCE)

14.12

Industry PE ratio

53.76

Beta (LTM)

0.71

P/B Ratio

4.95

Dividend Yield

0.32

PEG Ratio

7.27

Quarterly Earnings Growth YOY

24.56

EPS (TTM)

20.86

Sector

Pharmaceuticals

Book Value

249.59

Technical Analysis

Bearish

View Technical Analysis

How to invest in Ipca Laboratories Ltd

Investing in Ipca Laboratories Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Ipca Laboratories Ltd or IPCALAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Ipca Laboratories Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Ipca Laboratories Ltd with just a few clicks!

Ipca Laboratories Ltd Stock's Interest Amongst Investors

-54%

Period May 13, 2025 to Apr 13, 2025. Change in 30 Days vs previous period

Search interest for Ipca Laboratories Ltd Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Ipca Laboratories Ltd Valuation

Track how the P/E of Ipca Laboratories Ltd has moved over time to understand valuation trends.

Ipca Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (18.72x)

October 10, 2019

Today (47.35x)

May 9, 2025

Industry (53.76x)

May 9, 2025

Highest (65.89x)

September 25, 2024

LowHigh

Today’s Price to Earnings Ratio: 47.35x

Analysts Recommendation on Ipca Laboratories Ltd

Get updated buy, sell, and hold recommendations by analysts on Ipca Laboratories Ltd.

based on 21 analysts

BUY

65.00%

Buy

20.00%

Hold

15.00%

Sell

65% of analysts recommend a 'BUY' rating for Ipca Laboratories Ltd. Average target price of ₹1608.57

Source: S&P Global Market Intelligence

Analysts Forecast on Ipca Laboratories Ltd

Get share price movements and forecasts by analysts on Ipca Laboratories Ltd.

Ipca Laboratories Ltd price forecast by 21 analysts

Upside of18.12%

High

₹1918

Target

₹1608.57

Low

₹900

Ipca Laboratories Ltd target price ₹1608.57, a slight upside of 18.12% compared to current price of ₹1371.6. According to 21 analysts rating.

Source: S&P Global Market Intelligence

Ipca Laboratories Ltd Financials

Get the annual and quarterly financial summary of Ipca Laboratories Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue

(in ₹ Cr)

2053 (0%)2033 (1%)2093 (3%)2355 (13%)2245 (5%)
Net Income

(in ₹ Cr)

223 (0%)3 (99%)199 (6738%)245 (23%)277 (13%)
Net Profit Margin10.85% (0%)0.14% (99%)9.51% (6693%)10.42% (10%)12.35% (19%)
Value in ₹ crore
Details2021202220232024
Total Assets

(in ₹ Cr)

6099 (0%)7540 (24%)8465 (12%)8682 (3%)
Total Liabilities

(in ₹ Cr)

1346 (0%)2064 (53%)2588 (25%)2334 (10%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow

(in ₹ Cr)

561 (0%)1096 (95%)832 (24%)762 (8%)831 (9%)

Ipca Laboratories Ltd Index Inclusions

NIFTY PHARMA

₹21,102.70

0.15 (▲30.95%)

S&P BSE 250 LargeMidCap

₹10,590.10

3.83 (▲390.42%)

BSE Mid-Cap

₹43,731.60

3.85 (▲1620.1%)

S&P BSE 150 MidCap

₹15,213.91

3.75 (▲550.1%)

BSE 200

₹11,200.61

3.85 (▲415.62%)

Nifty Healthcare

₹13,765.50

0.68 (▲92.7%)

Nifty Midcap 150

₹20,331.50

3.75 (▲735.25%)

BSE Healthcare

₹41,599.29

0.91 (▲376.69%)

Nifty MidSmallcap 400

₹18,643.00

3.84 (▲689.25%)

Nifty LargeMidcap 250

₹15,698.40

-71.67 (▲-39717.65%)

S&P BSE 400 MidSmallCap

₹11,318.29

3.8 (▲413.83%)

Nifty 500

₹22,511.40

3.86 (▲835.85%)

BSE 500

₹35,412.40

3.83 (▲1307.1%)

Ipca Laboratories Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Ipca Laboratories Ltd.

  • Ipca Laboratories Ltd Earnings Results

    Ipca Laboratories Ltd’s net profit jumped 37.95% since last year same period to ₹248.14Cr in the Q3 2024-2025. On a quarterly growth basis, Ipca Laboratories Ltd has generated 8.13% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Ipca Laboratories Ltd Dividends November,2024

    In the quarter ending September 2024, Ipca Laboratories Ltd has declared dividend of ₹2 - translating a dividend yield of 0.29%.

    Read More about Dividends

Ipca Laboratories Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ipca Laboratories Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
44.72%
0.00
Foreign Institutions
10.76%
0.00
Mutual Funds
29.63%
0.00
Retail Investors
8.46%
0.00
Others
6.43%
0.00

Ipca Laboratories Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Ipca Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Ipca Laboratories Ltd
Ipca Laboratories Ltd
BUY34,549.4415.24%0.585297,705
Sanofi India Ltd
Sanofi India Ltd
BUY13,416.13-5.4%0.524132,013
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
BUY68,226.6913.71%0.563,16829,001
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
HOLD88,412.7534.29%0.643,85419,547
Abbott India Ltd
Abbott India Ltd
BUY64,100.6313.36%0.53NANA
See all

Ipca Laboratories Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in Ipca Laboratories Ltd.

  • Ipca Laboratories Reports Strong Financial Growth - 16 Apr, 2025

    Ipca Laboratories achieved 18% revenue growth in FY25, with EBITDA rising 29.8%. The company remains optimistic about future growth in chronic care and pain management segments.

  • IPCA Laboratories Shares Plummet Amid Tariff Concerns - 04 Apr, 2025

    On April 4, 2025, shares of Ipca Laboratories fell significantly due to U.S. President Trump's indication of impending tariffs on pharmaceutical imports, leading to a broader decline in the sector.

  • Ipca Laboratories Gains from Tariff Exemption News - 03 Apr, 2025

    Ipca Laboratories' promoters may be exempt from an open offer due to a stake increase. Shares surged 7% after the U.S. exempted pharmaceuticals from tariffs.

Insights on Ipca Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 59.59 Cr → 248.14 Cr (in ₹), with an average increase of 30.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 150.9% return, outperforming this stock by 109.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 54.1% return, outperforming this stock by 49.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.72% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 11.07% to 10.76% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, IPCALAB stock has moved down by -12.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.38K Cr → 2.26K Cr (in ₹), with an average decrease of 4.9% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.53% to 8.46% in Mar 2025 quarter

About Ipca Laboratories Ltd

Ipca Laboratories is a fully integrated global pharmaceutical company, manufacturing and marketing over 350 formulations and 80 APIs in over 100 countries around the world. Established in 1949, with its original name as Indian Pharmaceutical Combine Association Limited, Ipca has 17 manufacturing units in India, producing APIs and Formulations that are approved by major drug regulatory authorities, including the US FDA, UK MHRA, South African MCC, Brazilian ANVISA and Australian TGA. Apart from native India, Ipca is also a recognized supplier of intermediates and APIs⁠—Atenolol, Chloroquine Phosphate, Furosemide, and Pyrantel Salts⁠—globally. Ipca has received accreditation from ISO 9001, Forbes Global 200 best small companies, WHOGMP, INVIMA Colombian, and German standards, making it a respected name in the pharmaceutical industry. Recently, Ipca has acquired a number of companies, namely Krebs Biochemicals and Industries Ltd., Pisgah Labs Inc., Trophic Wellness Private Ltd, Lyka Labs Limited, and M/s. Ramdev Chemical Private Limited, to further extend its presence in the global market.

Revenue: ₹2,245.37Cr as on December 2024 (Q4 24)
Net Profit: ₹277.33Cr as on December 2024 (Q4 24)
Listing date: 03 Nov, 1994
Chairperson Name: Premchand Godha
OrganisationIpca Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPremchand Godha
E-voting on sharesClick here to vote

Indian Mutual Funds that own Ipca Laboratories Ltd

Check out the Mutual Funds with significant holdings in Ipca Laboratories Ltd.

FAQs

What is Ipca Laboratories Ltd price today?

Ipca Laboratories Ltd share price today stands at ₹1371.6, Open: ₹1386.8, Previous Close: ₹1361.8, High: ₹1386.8, Low: ₹1335.3, 52 Week High: ₹1755.9, 52 Week Low: ₹1052.

How to Buy Ipca Laboratories Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Ipca Laboratories Ltd shares

What are today's traded volumes of Ipca Laboratories Ltd?

Today's traded volume of Ipca Laboratories Ltd(IPCALAB) is 1.75L.

What is today's market capitalisation of Ipca Laboratories Ltd?

Today's market capitalisation of Ipca Laboratories Ltd(IPCALAB) is ₹34,549.44 Cr.

What is the 52 Week High and Low Range of Ipca Laboratories Ltd?

Ipca Laboratories Ltd (IPCALAB)
Price
52 Week High
₹1755.9
52 Week Low
₹1052

How much percentage Ipca Laboratories Ltd is down from its 52 Week High?

Ipca Laboratories Ltd (IPCALAB) share price is ₹1371.6. It is down -21.89% from its 52 Week High price of ₹1755.9

How much percentage Ipca Laboratories Ltd is up from its 52 Week low?

Ipca Laboratories Ltd (IPCALAB) share price is ₹1371.6. It is up 30.38% from its 52 Week Low price of ₹1052